Results 191 to 200 of about 9,409,817 (298)

Hospital Mergers, Hospital Choice, and Care Quality for Pregnant Enrollees in Medicaid.

JAMA Health Forum
Desai SM, Padmanabhan P, Glied S, Roberts ET.   +3 more
europepmc   +1 more source

Can digital M&As promote green innovation? Evidence from manufacturing companies in China. [PDF]

PLoS One
Wang X, Huang W.
europepmc   +1 more source

Regulation of the lncRNA NEAT1 by p53‐ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC

Molecular Oncology, EarlyView.
In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico, Veronica La Banca, Silvia D'Amico, Stefano Scalera, Sara Nicolai, Angelo Peschiaroli   +5 more
wiley   +1 more source

Confronting financial and political headwinds against sexual and reproductive health, rights, and justice.

BMJ
Clinton C.
europepmc   +1 more source

Human Rights First: Reflections from the Mobilization on Human Rights and Drug Policy Conference. [PDF]

Nordisk Alkohol Nark
Kankainen V, Tammi T.
europepmc   +1 more source

APOBEC3 activity and DNA polymerase‐ε deficiency are associated with distinct IDH1 R132 hotspot mutations

Molecular Oncology, EarlyView.
Isocitrate dehydrogenase 1 (IDH1) mutations are highly recurrent in multiple human cancer types, including cholangiocarcinoma and glioma. IDH1 R132C is the most common IDH1 mutation in cholangiocarcinoma and likely arises from APOBEC3A‐ or APOBEC3B‐mediated deamination.
Kelly E. Butler, Bilal A. Lone, Ecem Unal, A. Rouf Banday   +3 more
wiley   +1 more source

Innovation paradox in merger control: Professor Gonenc Gurkaynak

Market and Competition Law Review
José Pedro Oliveira Pinto
doaj   +1 more source

Ownership changes in the pharmaceutical industry: understanding the 2023 pharma mergers and acquisitions landscape of Europe. [PDF]

J Pharm Policy Pract
Fabian D, Wild C.
europepmc   +1 more source

p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer‐relevant paralog interplay

Molecular Oncology, EarlyView.
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault, Capucine Heraud, Mélissa Correia de Oliveira, Véronique Neaud, Valérie Valesco, Valérie Prouzet‐Mauleon, Béatrice Turcq, Jean‐William Dupuy, Anne‐Aurélie Raymond, Sabrina Croce, Frédéric Saltel, Valérie Lagrée, Violaine Moreau   +12 more
wiley   +1 more source

Advertising the leading US nicotine pouch brand: a content analysis of ZYN advertisements from 2019 to 2023. [PDF]

Tob Control
Lyu JC, Ozga JE, Stanton CA, Hrywna M, Ganz O, Cornacchione Ross J, Sharma A, Ling PM.   +7 more
europepmc   +1 more source